Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Molecular Biosystems|June 8, 2011
Guidelines for visualizing and annotating rule-based modelsLily A Chylek, Bin Hu, Michael L Blinov, et al.
Plos Computational Biology|January 18, 2019
Modeling cell line-specific recruitment of signaling proteins to the insulin-like growth factor 1 receptorKeesha E Erickson, Oleksii S Rukhlenko, Md Shahinuzzaman, et al.
BMC Systems Biology|August 24, 2012
Specification, annotation, visualization and simulation of a large rule-based model for ERBB receptor signalingMatthew S Creamer, Edward C Stites, Meraj Aziz, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 3, 2014
Transient expression in HEK 293 cells: an alternative to E. coli for the production of secreted and intracellular mammalian proteinsJoanne E Nettleship, Peter J Watson, Nahid Rahman-Huq, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 5, 2019
A Step-by-Step Guide to Using BioNetFitWilliam S Hlavacek, Jennifer A Csicsery-Ronay, Lewis R Baker, et al.
British Journal of Cancer|July 20, 2017
Clinical study of genomic drivers in pancreatic ductal adenocarcinomaMichael T Barrett, Ray Deiotte, Elizabeth Lenkiewicz, et al.
Journal of Immunotherapy and Precision Oncology|March 2, 2026
Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced <i>KRAS</i>-Mutated Metastatic Pancreatic CancerMuhammad Rizwan Khawaja, Gayle Jameson, Derek Cridebring, et al.
Cell Systems|July 16, 2018
Dissecting RAF Inhibitor Resistance by Structure-based Modeling Reveals Ways to Overcome Oncogenic RAS SignalingOleksii S Rukhlenko, Fahimeh Khorsand, Aleksandar Krstic, et al.
Journal of Gastrointestinal Oncology|January 5, 2018
A phase 2 trial of personalized cytotoxic therapy based on tumor immunohistochemistry in previously treated metastatic pancreatic cancer patientsRamesh K Ramanathan, Glen J Weiss, Richard G Posner, et al.
Pageof 17